Skip to main content

Table 5 Retention on ART according to clinical parameters

From: Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: results from a nationwide systematic random sampling

  

Reference treatment centres

HIV management units

Total

n/N

%

n/N

%

n/N

%

WHO clinical stage

I

100/183

54.6%

124/171

72.5%

224/354

63.3%

II

71/158

44.9%

94/132

71.2%

165/290

56.9%

III

299/545

54.9%

493/734

67.2%

792/1279

61.9%

IV

33/99

33.3%

100/141

70.9%

133/240

55.4%

CD4 count

0–350

576/1114

51.7%

787/1164

67.6%

1363/2279

59.8%

351–500

55/93

59.1%

92/130

70.8%

147/223

65.9%

Above 500

19/35

54.3%

54/85

63.5%

73/120

60.8%

Total

 

925/1706

54.2%

1098/1643

66.8%

2023/3349

60.4%

  1. Legend. n: frequency; %: proportion of patients in care for each region and in the total study population; Reference treatment centre provides mentorship to HIV management units within his health area. In bold are the most prevalent data on retention according to WHO clinical stage and CD4 count